Morgan Stanley’s Sana Biotechnology SANA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.04M | Buy |
1,479,795
+654,131
| +79% | +$1.79M | ﹤0.01% | 4230 |
|
|
2025
Q1 | $1.39M | Sell |
825,664
-1,084,555
| -57% | -$1.82M | ﹤0.01% | 4830 |
|
|
2024
Q4 | $3.11M | Buy |
1,910,219
+7,154
| +0.4% | +$11.7K | ﹤0.01% | 4370 |
|
|
2024
Q3 | $7.92M | Buy |
1,903,065
+284,724
| +18% | +$1.18M | ﹤0.01% | 3614 |
|
|
2024
Q2 | $8.84M | Buy |
1,618,341
+128,661
| +9% | +$702K | ﹤0.01% | 3412 |
|
|
2024
Q1 | $14.9M | Buy |
1,489,680
+22,876
| +2% | +$229K | ﹤0.01% | 2995 |
|
|
2023
Q4 | $5.98M | Buy |
1,466,804
+873,841
| +147% | +$3.57M | ﹤0.01% | 4268 |
|
|
2023
Q3 | $2.29M | Buy |
592,963
+3,140
| +0.5% | +$12.2K | ﹤0.01% | 4300 |
|
|
2023
Q2 | $3.52M | Buy |
589,823
+104,082
| +21% | +$620K | ﹤0.01% | 4026 |
|
|
2023
Q1 | $1.59M | Buy |
485,741
+37,587
| +8% | +$123K | ﹤0.01% | 4589 |
|
|
2022
Q4 | $1.77M | Sell |
448,154
-247,231
| -36% | -$977K | ﹤0.01% | 4536 |
|
|
2022
Q3 | $4.17M | Sell |
695,385
-231,638
| -25% | -$1.39M | ﹤0.01% | 3842 |
|
|
2022
Q2 | $5.96M | Sell |
927,023
-858,870
| -48% | -$5.52M | ﹤0.01% | 3601 |
|
|
2022
Q1 | $14.8M | Buy |
1,785,893
+1,055,116
| +144% | +$8.72M | ﹤0.01% | 2443 |
|
|
2021
Q4 | $11.3M | Sell |
730,777
-167,713
| -19% | -$2.6M | ﹤0.01% | 2821 |
|
|
2021
Q3 | $20.2M | Buy |
898,490
+39,182
| +5% | +$882K | ﹤0.01% | 2072 |
|
|
2021
Q2 | $16.9M | Buy |
859,308
+43,788
| +5% | +$861K | ﹤0.01% | 2339 |
|
|
2021
Q1 | $27.3M | Buy |
+815,520
| New | +$27.3M | ﹤0.01% | 1641 |
|